ESTRO 2021 Abstract Book

S1205

ESTRO 2021

PO-1469 A comprehensive score for financial toxicity in Japanese women: a pilot study before COVID-19 era C. Makita 1 , M. Ito 1 , T. Kumano 1 , S. Okada 2 , Y. Kajiura 2 , O. Tanaka 3 , M. Matsuo 1 1 Gifu University, Radiology, Gifu, Japan; 2 Gifu prefectural general medical center, Radiation oncology, Gifu, Japan; 3 Asahi University , Radiation oncology, Gifu, Japan Purpose or Objective Patients with financial toxicity (FT) have a lower quality of life and survival. In Japan, although the universal health insurance system has provided comprehensive coverage to all Japanese citizens, FT is increasingly recognized as an adverse outcome of cancer treatment. The poverty rate for elderly Japanese women is increasing; however , the FT of cancer treatment has been poorly studied in Japan. The comprehensive score for FT (COST) questionnaire is a tool to measure FT. In our study, we examined COST questionnaire among adult Japanese women receiving radiotherapy for breast cancer. Materials and Methods Patients who were aged >18, had stage I–III A breast cancer, and received radiotherapy after breast-conserving surgery or mastectomy were eligible for the study. In addition to COST survey, socioeconomic characteristics were determined using a questionnaire and medical records. Results All 17 patients we approached (100%) responded to the questionnaire. The median COST score was 17 (range, 9–38). Ten (59%) and five (29%) patients suffered grade 1 FT (COST score, 14–25) and grade 2 FT (COST score, 1–13), respectively. On univariant analyses, part-time job ( P = .03), and lower household savings ( P < .001) were negatively associated with COST score. Lower household income ( P = .12) and use of strategies to cope with the cost of cancer care expenses (included using savings) to pay for cancer treatment ( P = .13) did not show statistically significant associations. Conclusion Our preliminary data showed that despite the existing universal health insurance system, some Japanese women experienced meaningful financial toxicity during radiotherapy. This is a preliminary report with a small number of patients before COVID-19 era. COVID-19 has the potential to affect patients economically. Therefore, a prospective study is underway to confirm the results under COVID-19 era. PO-1470 Fear is not a Barrier to Radiation Therapy in highly educated members of the public C. Poole 1 1 Trinity College,St. James’s Cancer Institute, Discipline of Radiation Therapy, Dublin, Ireland Purpose or Objective One in four eligible patients do not receive radiation therapy (RT) for the management of their disease. An underlying reason may be fear of treatment efficacy. The aim of this study was to establish the knowledge and misconceptions towards the efficacy, safety, and delivery of this treatment modality in the public. Materials and Methods An anonymous questionnaire made available to participants of an international massive open online course aimed at educating the public about radiation therapy. Consenting participants were invited to first complete a 16-points knowledge quiz assessing the process and lifestyle impact of RT. Common misconceptions of efficacy and safety were next rated. Cultural and practical considerations associated with access to RT were finally assessed. Results 393 participants completed the survey across 59 countries. 335 (85%) were considered highly educated having completed third level education. 33.5% were 18-34 years old, and 20% were 65 and above. 90% had a good (9- 11) to excellent (12-16) knowledge score. Participants generally disagreed with common misconceptions. The majority disagreed with the statement that chemotherapy or surgery is more effective. 95% agreed that RT was a safe treatment and 60% had no fear or anxiety about receiving RT. 80% stated that they would follow their physician’s advice if it meant cure. No cultural impact was identified. Most patients identified travel and financial issues as a negative consequence of receiving RT. Conclusion This study identifies that concerns over treatment safety is not common in highly educated members of the public. Financial and practical burden could dominate the recognised lack of access to radiotherapy in eligible patients. Further evaluation of these barriers is warranted. PO-1471 Establishing a benchmark of Diversity, Equity and Inclusion in radiation oncology A. Gasnier 1,2 , B.A. Jereczek-Fossa 3,4 , B.A. Jereczek-Fossa 5 , M. Pepa 4 , M. Spalek 6,7 , J. Bertholet 8,9 , J. Bibault 10 , J. Bibault 9 , L. Mullaney 11 , L. Mullaney 9 , M. Bittner 12,7 , S. Perryck 13,7 , S.F. Petit 14 , S.F. Petit 7 , C. Chargari 1,7 , L. Dubois 15,7 , P. Franco 16 , P. Franco 9 1 Gustave Roussy Cancer Campus, Radiotherapy Department, Villejuif, France; 2 Paris-Sud University - Gustave Roussy - Inserm - Paris-Saclay University, U1030 Molecular Radiotherapy and Innovative Therapeutics, , Villejuif, France; 3 University of Milan, Department of Oncology and Hemato-oncology, Milan, Italy; 4 IEO European Institute of Oncology, IRCCS, Division of Radiotherapy, Milan, Italy; 5 European Society for Radiotherapy & Oncology (ESTRO), National Societies Committee, Brussels, Belgium; 6 Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland; 7 European Society for Radiotherapy & Oncology (ESTRO), Young Committee, Brussels, Belgium; 8 Inselspital, Division of Medical Radiation Physics, Bern University Hospital, Switzerland; 9 European Society for Radiotherapy & Oncology (ESTRO), Young Committee , Brussels, Belgium; 10 Hopital Europeen Georges Pompidou - Universite Paris Descartes, Radiation Oncology Department, Paris, France; 11 School of Medicine, Trinity College Dublin, Applied Radiation Therapy Trinity Research Group, Discipline of Radiation Therapy,